LH News and Press, Laboratory Corporation of America Holdings From 02/19/23

Summary Today, we revisit Fulgent Genetics. The company continues to manage through a huge drop off in Covid testing revenues as the pandemic ebbs. However, 'core' testing sales are seeing impressive growth and the company has a massive amount of cash on its balance sheet. An u...

Laboratory Corporation of America Holdings (LH) Q4 2022 Earnings Conference Call February 16, 2023 09:00 ET Company Participants Chas Cook - Vice President of Investor Relations Adam Schechter - President, Chief Executive Officer & Chairman Glenn Eisenberg - Execut...

Labcorp ( NYSE: LH ) posted its fourth consecutive quarterly revenue decline on Thursday, estimating up to a 90% decline in COVID testing revenue this year amid the waning pandemic impact. However, the company’s 2023 earnings guidance at $16.00 – $18.00 for adjusted ...

Laboratory Corporation of America press release ( NYSE: LH ): Q4 Non-GAAP EPS of $4.14 in-line. Revenue of $3.7B (-8.9% Y/Y) misses by $40M . Full-Year 2023 Guidance: Adjusted EPS of $16.00 to $18.00 vs. consensus of $17.71 and Free Cash Flow of $1.0 billion to $...

Company Provides 2023 Guidance Revenue: Q4 of $3.7 billion, versus $4.1 billion last year; Full year of $14.9 billion, versus $16.1 billion last year Diluted EPS: Q4 of $0.86, versus $5.75 last year; Full year of $13.97, versus $24.39 last year Adjusted EPS: Q4 of $4.14, versus $6...

Fortrea Will Become a Leading, Pure-play CRO Focused on Driving Innovation and Improving Patient Outcomes Worldwide Spin-off Remains on Track to Be Completed in Mid-2023 Labcorp (NYSE: LH), a leading global life sciences company, today announced that the new company to be formed b...

Summary Labcorp is a strong player in the diagnostics space, with a network of 2,000 patient service centers. It has a long growth runway as its efficient scale makes it appealing for hospitals to outsource this essential function. I also highlight the dividend, outlook, valuation, ...

Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the fourth quarter and full year 2022 before the market opens on Thursday, Feb. 16, 2023. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results...

Mr. Pike Brings 30 Years of Industry Experience and a Proven Track Record of Driving Growth Labcorp (NYSE: LH), a leading global life sciences company, today announced that Thomas (Tom) Pike will join Labcorp as president and chief executive officer of its Drug Development Clinical ...

Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10 at 4:30 p.m. (PT). A live audio webcast of the fireside chat...